Balance Sheet
Cash Flow Statement
Capital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Entera Bio (ENTX) Cash from Operations (2018 - 2025)

Entera Bio has reported Cash from Operations over the past 8 years, most recently at 1833000.0 for Q4 2025.

  • For the quarter ending Q4 2025, Cash from Operations fell 24.95% year-over-year to 1833000.0, compared with a TTM value of 7370000.0 through Dec 2025, down 8.1%, and an annual FY2025 reading of 7370000.0, down 8.1% over the prior year.
  • Cash from Operations came in at 1833000.0 for Q4 2025, up from 2502000.0 in the prior quarter.
  • In the past five years, Cash from Operations ranged from a high of 1335000.0 in Q2 2024 to a low of 4792000.0 in Q1 2022.
  • Median Cash from Operations over the past 5 years was 2060000.0 (2021), compared with a mean of 2153000.0.
  • The sharpest move saw Cash from Operations crashed 106.46% in 2022, then surged 66.42% in 2023.
  • Over 5 years, Cash from Operations stood at 2512000.0 in 2021, then increased by 19.94% to 2011000.0 in 2022, then tumbled by 30.13% to 2617000.0 in 2023, then soared by 43.94% to 1467000.0 in 2024, then fell by 24.95% to 1833000.0 in 2025.
  • Per Business Quant, the three most recent readings for ENTX's Cash from Operations are 1833000.0 (Q4 2025), 2502000.0 (Q3 2025), and 1631000.0 (Q2 2025).